V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10440513 | 10033452 | 1.55 | 101.6 | 03 | 2017-05-03 | 2017-05-06 | IBRUTINIB | 02 | N | IBRUTINIB | 100403206 |
| 10440540 | 10033453 | 1.8 | null | 03 | 2019-12-03 | 2019-12-03 | Docetaxel | 02 | Y | DOCETAXEL | 101797039 |
| 10440559 | 10033454 | null | null | Palliative (P) | 2021-10-18 | 2021-10-23 | IBRUTINIB | N | N | IBRUTINIB | 100655841 |
| 10440566 | 10033455 | 1.72 | 73 | null | 2020-04-23 | 2020-05-06 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101217873 |
| 10440594 | 10033456 | null | null | null | 2020-08-27 | 2020-08-29 | Rituximab | 02 | null | RITUXIMAB | 100686687 |
| 10440597 | 10033457 | 1.75 | 101.5 | null | 2021-10-06 | 2021-10-07 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100392158 |
| 10440602 | 10033458 | 1.5 | 79 | Adjuvant (A) | 2019-02-08 | 2019-02-08 | IBRUTINIB | 02 | N | IBRUTINIB | 101184031 |
| 10440604 | 10033459 | 1.88 | 86 | 03 | 2015-10-17 | 2017-08-16 | Capecitabine + Oxaliplatin 21day | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100537630 |
| 10440629 | 10033460 | 1.71 | 92.6 | Palliative (P) | 2021-03-06 | 2021-04-02 | Capecitabine | 02 | N | CAPECITABINE | 101026501 |
| 10440664 | 10033461 | 1.55 | 98.8 | Palliative (P) | 2018-08-21 | 2018-08-21 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 101418561 |
| 10440683 | 10033462 | 1.7 | 126 | Adjuvant (A) | 2015-12-19 | 2015-12-26 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101769286 |
| 10440688 | 10033463 | 1.64 | 67.8 | null | 2020-09-23 | 2020-10-13 | Docetaxel | 02 | N | DOCETAXEL | 101193804 |
| 10440692 | 10033464 | 1.78 | 63.2 | 03 | 2017-02-18 | 2017-02-19 | Rituximab | 02 | N | RITUXIMAB | 100713973 |
| 10440702 | 10033465 | 1.7 | null | Palliative (P) | 2019-11-04 | 2019-11-14 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101607869 |
| 10440713 | 10033466 | 1.76 | 68.3 | Curative (C) | 2020-04-04 | 2020-04-04 | Rituximab | 02 | N | RITUXIMAB | 101449588 |
| 10440719 | 10033467 | 1.83 | 93 | Curative (C) | 2020-11-05 | 2020-11-06 | IBRUTINIB | 02 | N | IBRUTINIB | 101054920 |
| 10440760 | 10033468 | 1.61 | 64 | Curative (C) | 2020-06-22 | 2020-06-23 | Docetaxel | 02 | N | DOCETAXEL | 100112189 |
| 10440764 | 10033469 | 1.74 | 77 | Palliative (P) | 2019-12-15 | 2020-01-03 | IBRUTINIB | 02 | N | IBRUTINIB | 101756223 |
| 10440769 | 10033470 | 1.61 | 67.1 | null | 2022-02-20 | 2022-02-27 | Capecitabine | 02 | null | CAPECITABINE | 100812328 |
| 10440812 | 10033471 | 1.67 | 96 | Curative (C) | 2016-12-30 | 2017-01-03 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101341631 |
| 10440816 | 10033472 | 1.78 | 71 | null | 2016-07-17 | 2016-09-24 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100498463 |
| 10440823 | 10033473 | 1.75 | 101 | Adjuvant (A) | 2021-07-08 | 2021-07-15 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101646437 |
| 10440884 | 10033474 | 1.6 | 71.85 | null | 2022-01-07 | 2022-01-07 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101689069 |
| 10440905 | 10033475 | 1.6 | 66 | Neo-adjuvant (N) | 2017-04-05 | 2017-04-11 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100392834 |
| 10440910 | 10033476 | 1.71 | null | Palliative (P) | 2017-09-22 | 2017-09-22 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101491428 |
| 10440916 | 10033477 | 1.71 | 77.7 | 03 | 2016-11-28 | 2016-12-05 | Capecitabine + Oxaliplatin 14day | 02 | N | RITUXIMAB | 100804497 |
| 10440929 | 10033478 | 1.78 | 59 | 03 | 2016-02-17 | 2016-02-17 | IBRUTINIB | 02 | N | IBRUTINIB | 101191114 |
| 10440933 | 10033479 | 1.62 | 88.9 | Adjuvant (A) | 2017-05-09 | 2017-05-22 | IBRUTINIB | 02 | N | IBRUTINIB | 100407563 |
| 10440939 | 10033480 | 1.84 | 87.3 | null | 2018-04-10 | 2018-04-13 | Rituximab | 02 | null | RITUXIMAB | 100229110 |
| 10440942 | 10033481 | 1.75 | 85.2 | Neo-adjuvant (N) | 2019-03-04 | 2019-03-13 | Rituximab | 02 | null | RITUXIMAB | 100657576 |
| 10440962 | 10033482 | 1.6 | 71 | 03 | 2018-11-30 | 2018-12-04 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101719974 |
| 10440971 | 10033483 | 0 | 68.3 | Palliative (P) | 2019-09-06 | 2019-09-07 | IBRUTINIB | 02 | N | IBRUTINIB | 101346422 |
| 10440983 | 10033484 | null | null | null | 2021-03-04 | 2021-03-07 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101718522 |
| 10440994 | 10033485 | 1.65 | 63 | Palliative (P) | 2019-10-03 | 2019-11-20 | IBRUTINIB | 02 | N | IBRUTINIB | 100397166 |
| 10441000 | 10033486 | 1.54 | 90 | Curative (C) | 2019-10-08 | 2019-10-18 | Rituximab | 02 | null | RITUXIMAB | 101251497 |
| 10441032 | 10033487 | 1.79 | 58.8 | Disease modification (D) | 2019-09-11 | 2019-09-16 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101577025 |
| 10441048 | 10033488 | 1.66 | 67 | Adjuvant (A) | 2016-10-31 | 2016-11-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100768735 |
| 10441053 | 10033489 | 1.65 | 108 | 03 | 2019-06-13 | 2019-06-19 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101174591 |
| 10441058 | 10033490 | 1.84 | 74.5 | null | 2019-02-28 | 2019-03-16 | Capecitabine | 02 | N | CAPECITABINE | 100249438 |
| 10441076 | 10033491 | null | 69.4 | null | 2016-11-12 | 2016-11-22 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100012786 |
| 10441087 | 10033492 | null | 92 | Adjuvant (A) | 2019-06-24 | 2019-06-24 | IBRUTINIB | 02 | N | IBRUTINIB | 101659340 |
| 10441093 | 10033493 | 1.62 | 77 | Palliative (P) | 2018-01-29 | 2018-02-24 | Rituximab | 02 | N | RITUXIMAB | 100906131 |
| 10441107 | 10033494 | 1.75 | 0 | Neo-adjuvant (N) | 2019-06-23 | 2019-06-24 | CHOP R | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100257214 |
| 10441114 | 10033495 | 1.59 | 81 | Curative (C) | 2018-03-11 | 2018-03-11 | Capecitabine 35days + RT | 02 | null | CAPECITABINE | 100035891 |
| 10441127 | 10033496 | null | 81.2 | Curative (C) | 2021-04-25 | 2021-05-07 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100397160 |
| 10441137 | 10033497 | 1.6 | 76.4 | Palliative (P) | 2017-08-04 | 2017-08-07 | IBRUTINIB | 02 | N | IBRUTINIB | 100945326 |
| 10441147 | 10033498 | 1.69 | 61 | null | null | 2017-06-01 | Rituximab | 02 | null | RITUXIMAB | 101427299 |
| 10441149 | 10033499 | 1.74 | 80 | 03 | 2018-02-28 | 2018-03-22 | Rituximab | 02 | N | RITUXIMAB | 101862769 |
| 10441159 | 10033500 | 1.8 | 66.8 | Palliative (P) | 2016-03-08 | 2016-03-08 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101366623 |
| 10441188 | 10033501 | 1.63 | 90.9 | Disease modification (D) | 2021-09-27 | 2021-10-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 101437619 |